Advanced search
Publication Cover
Modern Rheumatology Volume 16, 2006 - Issue 4
Journal homepage
31
Views
19
CrossRef citations to date
0
Altmetric
CASE REPORT

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

Shunsuke MoriDivision of Rheumatology, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, 2659 Suya Kohshi, Kumamoto 861-1196, JapanCorrespondence[email protected]
,
Fumiya ImamuraDivision of Respiratory Medicine, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, Kumamoto, Japan
,
Chikage KiyofujiDivision of Respiratory Medicine, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, Kumamoto, Japan
&
Mineharu SugimotoDivision of Respiratory Medicine, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, Kumamoto, Japan
Pages 251-255 | Received 01 Feb 2006, Accepted 17 May 2006, Published online: 02 Jan 2014

References

  • Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586–93.
  • Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675–81.
  • Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594–602.
  • St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432–3.
  • Cannon G, Strand V, Scarazzini L, Holden W. Comparison of adverse event reporting rates for etanercept, infliximab, leflunomide and methotrexate between September 1998 and June 2003. Arthritis Rheum Suppl 2004;50:5561.
  • Chatterjee S. Severe interstitial pneumonitis associated with infliximab therapy. Scand J Ftheumatol 2004;33:276–7.
  • Courtney PA, Alderdice J, Whitehead EM. Comment on methotr-exate pneumonitis after initiation of infliximab therapy for rheu-matoid arthritis. Arthritis Rheum 2003;49:617; author reply 617–8.
  • Kramer N, Chuzhin Y, Kaufman LD, Ritter JM, Rosenstein ED. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002;47:670–1.
  • Ostor AJ, Crisp AJ, Somerville MF, Scott DG. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ 2004;329:1266.
  • Zisman DA, McCune WJ, Tino G, Lynch JP 3rd. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001;18: 243–52.
  • Torre-Cisneros J, Del Castillo M, Caston JJ, Castro MC, Perez V, Collantes E. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. Rheumatology (Oxford) 2005;44:1132–5.
  • Alarcon GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med 1997;127:356–64.
  • Kuroki M, Noguchi Y, Shimono M, Tomono K, Tashiro T, Obata Y, et al. Repression of bleomycin-induced pneumopathy by TNF. J Immunol 2003;170:567–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.